What dose of Lantus (insulin glargine) should a patient with type 2 diabetes start with after 6 units of Novolog (insulin aspart) lowered their blood glucose from 295 to 118?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Lantus Dose After Novolog Response

Start with 10 units of Lantus once daily at the same time each day. 1, 2

Rationale for This Recommendation

The patient's response to 6 units of Novolog (blood glucose dropping from 295 to 118 mg/dL, a reduction of 177 mg/dL) demonstrates significant insulin sensitivity, suggesting they are likely insulin-naive or on minimal insulin therapy. 1

Standard Initial Dosing Guidelines

  • For insulin-naive patients with type 2 diabetes, the American Diabetes Association recommends starting Lantus at 10 units once daily or 0.1-0.2 units/kg body weight. 1, 2
  • The FDA label for Lantus specifies a starting dose of 0.2 units/kg or up to 10 units once daily for type 2 diabetes patients not currently treated with insulin. 2
  • The 10-unit starting dose is the most commonly recommended and safest initial approach, particularly when body weight is unknown. 1

Why Conservative Dosing is Critical Here

  • The dramatic 177 mg/dL drop from just 6 units of rapid-acting insulin indicates this patient has good insulin sensitivity. 1
  • Using the insulin sensitivity factor formula (1500 ÷ Total Daily Dose), if we estimate their sensitivity, they appear to be highly responsive to insulin, making aggressive initial dosing inappropriate. 1
  • Starting with 10 units minimizes hypoglycemia risk while providing adequate basal coverage. 1, 3

Titration Protocol After Initiation

Increase Lantus by 2-4 units every 3 days based on fasting glucose patterns until reaching target of 80-130 mg/dL: 1

  • If fasting glucose is 140-179 mg/dL: increase by 2 units every 3 days 1
  • If fasting glucose is ≥180 mg/dL: increase by 4 units every 3 days 1
  • If hypoglycemia occurs without clear cause: reduce dose by 10-20% immediately 1

Essential Monitoring Requirements

  • Daily fasting blood glucose monitoring is essential during the titration phase. 1
  • Administer Lantus at the same time every day (can be any time, but must be consistent). 2
  • Check for signs of overbasalization when dose exceeds 0.5 units/kg/day, including bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia episodes, or high glucose variability. 1

Critical Threshold to Watch

When Lantus dose approaches 0.5-1.0 units/kg/day without achieving glycemic targets, adding prandial insulin becomes more appropriate than continuing to escalate basal insulin alone. 1 This prevents "overbasalization" which leads to increased hypoglycemia risk without improved control. 1

Foundation Therapy Considerations

  • Continue metformin (unless contraindicated) when starting Lantus, as this combination provides superior glycemic control with reduced insulin requirements and less weight gain. 1
  • Consider discontinuing sulfonylureas when starting insulin to reduce hypoglycemia risk. 1

Common Pitfalls to Avoid

  • Never start with aggressive dosing (>0.2 units/kg/day) in patients demonstrating high insulin sensitivity like this one. 1
  • Do not delay dose titration—adjust every 3 days based on fasting glucose patterns, not weekly or monthly. 1
  • Never rely solely on correction insulin (sliding scale) without adequate basal coverage. 1

Related Questions

What is the appropriate Lantus (glargine) dose and insulin regimen for a patient with a hemoglobin A1c (HbA1c) of 13.1%, transitioning off an insulin drip, with a body mass index (BMI) of 38 and impaired renal function (creatinine 0.77), who is new to insulin therapy?
Should a provider add Lantus (insulin glargine) 20 units at bedtime to a patient's regimen of Jardiance (empagliflozin) 10 mg daily and metformin 500 mg twice daily, with an A1c of 6.9 and blood sugars in the 200s?
What adjustments should be made to the treatment plan for a patient with uncontrolled hyperglycemia on Lantus (insulin glargine) 12 units?
Is it better to administer 54 units of Lantus (insulin glargine) once daily or twice daily?
What is the recommended increase in Lantus (insulin glargine) dose for a patient with hyperglycemia, who previously used an insulin pump with basal needs ranging from 19-29 units, and is now taking 10 units of Lantus with a fasting blood glucose level of 220 and overnight blood glucose level of 179?
What are the guidelines and standard of care for a patient with a history of recent chemotherapy and immunotherapy, presenting with a perforated bowel, sepsis, hypocortisolism, and anemia?
What are the safest Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for an arthritis patient with hyperuricemia and a history of kidney disease?
Do you recommend starting antibiotic therapy in a diabetic patient with a two-week-old thumb blister and no visible signs of infection while awaiting a referral from a hand specialist?
Can taking Xanax (alprazolam) to fall asleep cause hiccups the next morning?
Is acetaminophen a better option than ibuprofen for pain management in a patient with a history of gastrointestinal conditions such as gastritis, ulcers, or GERD?
What is the first-line cream treatment for a patient with a rash on the bilateral thighs, front and back?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.